MX353301B - Composiciones tripeptidicas y metodos para tratamiento de diabetes. - Google Patents
Composiciones tripeptidicas y metodos para tratamiento de diabetes.Info
- Publication number
- MX353301B MX353301B MX2013009223A MX2013009223A MX353301B MX 353301 B MX353301 B MX 353301B MX 2013009223 A MX2013009223 A MX 2013009223A MX 2013009223 A MX2013009223 A MX 2013009223A MX 353301 B MX353301 B MX 353301B
- Authority
- MX
- Mexico
- Prior art keywords
- diabetes
- methods
- treatment
- compositions
- peptide
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000001280 Prediabetic State Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 201000009104 prediabetes syndrome Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161441748P | 2011-02-11 | 2011-02-11 | |
| PCT/US2012/024684 WO2012109561A2 (en) | 2011-02-11 | 2012-02-10 | Peptide compositions and methods for treating patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013009223A MX2013009223A (es) | 2014-01-23 |
| MX353301B true MX353301B (es) | 2018-01-08 |
Family
ID=45852697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013009223A MX353301B (es) | 2011-02-11 | 2012-02-10 | Composiciones tripeptidicas y metodos para tratamiento de diabetes. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8664177B2 (OSRAM) |
| EP (1) | EP2683393B1 (OSRAM) |
| JP (3) | JP5946473B2 (OSRAM) |
| CN (2) | CN103458911B (OSRAM) |
| AU (1) | AU2012214283B2 (OSRAM) |
| CA (1) | CA2827029C (OSRAM) |
| DK (1) | DK2683393T3 (OSRAM) |
| ES (1) | ES2673672T3 (OSRAM) |
| HU (1) | HUE038787T2 (OSRAM) |
| MX (1) | MX353301B (OSRAM) |
| WO (1) | WO2012109561A2 (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2827029C (en) | 2011-02-11 | 2019-07-02 | The Regents Of The University Of Michigan | Tripeptide compositions and methods |
| US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
| US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
| US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
| US20180074053A1 (en) * | 2015-04-03 | 2018-03-15 | Zhongmin Ma | Treatment of diabetes using agonists of the mas-related gpcr d |
| KR101909052B1 (ko) | 2017-02-09 | 2018-10-17 | 강원대학교산학협력단 | 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물 |
| WO2018237010A2 (en) | 2017-06-20 | 2018-12-27 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Vaccine compositions and methods of using the same |
| JP7068942B2 (ja) * | 2018-06-25 | 2022-05-17 | サンスター株式会社 | トリペプチド含有組成物 |
| EP3833373A4 (en) * | 2018-08-10 | 2022-05-04 | Diapin Therapeutics LLC | TRIPEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISEASES |
| WO2022040222A1 (en) * | 2020-08-18 | 2022-02-24 | The Regents Of The University Of Michigan | N-acyl amino acid products and uses |
| CN115252758A (zh) * | 2022-08-16 | 2022-11-01 | 中国科学院南海海洋研究所 | 线性小分子肽类似物在制备抗肥胖和降糖药物中应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL275394A (OSRAM) | 1961-02-28 | |||
| AU426743B2 (en) | 1967-09-21 | 1972-07-21 | MONASH UNIVERSITY, and ICI AUSTRALIA LIMITED | Processes forthe production of peptides and proteins |
| GB8500209D0 (en) | 1985-01-04 | 1985-02-13 | Ceskoslovenska Akademie Ved | Synthetic polymeric drugs |
| JPH04149139A (ja) * | 1990-10-12 | 1992-05-22 | Nippon Steel Corp | 血糖降下剤 |
| SE520392C2 (sv) | 1996-09-27 | 2003-07-01 | Creative Peptides Sweden Ab C | Specifika peptider för behandling av diabetes mellitus |
| US6069129A (en) * | 1998-03-13 | 2000-05-30 | Mrs, Llc | Elastin derived composition and method of using same |
| AU5014500A (en) | 1999-05-12 | 2000-11-21 | Board Of Regents For Oklahoma State University, The | Reagent and process for peptide/protein differentiation using circular dichroism detection |
| AU2001275018B2 (en) | 2000-05-30 | 2008-04-03 | Connective Tissue Imagineering Llc | Composition and method for enhancing elasticity of tissue |
| SE0002934D0 (sv) * | 2000-08-17 | 2000-08-17 | Axon Biochemicals Bv | New aporphine esters and in their use in therapy |
| WO2003022991A2 (en) | 2001-09-07 | 2003-03-20 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| WO2002020723A2 (en) | 2000-09-08 | 2002-03-14 | Board Of Regents, The University Of Texas System | Compositions and methods for targeting peptides in humans in vivo |
| AU2001288914A1 (en) | 2000-09-08 | 2002-03-22 | Board Of Regents, The University Of Texas System | Biopanning and rapid analysis of selective interactive ligands (brasil) |
| GB0022342D0 (en) | 2000-09-12 | 2000-10-25 | Creative Peptides Sweden Ab | Reduction of the electrocardiographic QT interval |
| FI114710B (fi) * | 2001-03-12 | 2004-12-15 | Ctt Cancer Targeting Tech Oy | Leukosyytti-integriinien uusia peptidiligandeja |
| WO2003024995A1 (en) * | 2001-09-19 | 2003-03-27 | Tripep Ab | Molecules that block viral infectivity and methods of use thereof |
| WO2003035028A1 (en) | 2001-10-19 | 2003-05-01 | Nektar Therapeutics | Modulating charge density to produce improvements in the characteristics of spray-dried proteins |
| GB0218970D0 (en) | 2002-08-14 | 2002-09-25 | Creative Peptides Sweden Ab | Fragments of Insulin c-peptide |
| WO2005079755A2 (en) | 2004-02-12 | 2005-09-01 | Nektar Therapeutics | Interleukin-13 antagonist powders, spray-dried particles, and methods |
| EP1765403A4 (en) | 2004-05-10 | 2011-03-30 | Univ Utah Res Found | COMBINED ACTIVE AND PASSIVE TARGETING OF BIOLOGICALLY ACTIVE ACTIVE SUBSTANCES |
| WO2007046818A2 (en) | 2004-11-16 | 2007-04-26 | Board Of Regents, The University Of Texas System | Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display |
| WO2006108211A1 (en) | 2005-02-25 | 2006-10-19 | The Murdoch Childrens Research Institute | Fragments of von willebrand factor a-related protein |
| GB0511269D0 (en) | 2005-06-02 | 2005-07-13 | Creative Peptides Sweden Ab | Sustained release preparation of pro-insulin C-peptide |
| GB0601950D0 (en) | 2006-01-31 | 2006-03-15 | Creative Peptides Sweden Ab | Compositions and methods of treating diabetes |
| JPWO2008004610A1 (ja) * | 2006-07-05 | 2009-12-03 | 国立大学法人 東京大学 | ナンセンス変異型遺伝性疾患の治療方法 |
| US20090092660A1 (en) | 2006-08-09 | 2009-04-09 | Trinity Biosystems, Inc. | Methods and compositions for needleless delivery of particles |
| CZ2006592A3 (cs) | 2006-09-18 | 2008-03-19 | Zentiva, A. S. | Polymerní lécivo a zpusob jeho výroby |
| WO2009026614A1 (en) * | 2007-08-24 | 2009-03-05 | Dia-B Tech Limited | Hypoglycaemic tripeptide and methods of use thereof |
| KR100947547B1 (ko) * | 2009-07-23 | 2010-03-12 | 월드웨이(주) | 실크 펩타이드를 유효성분으로 하는 당뇨 치료 또는 예방용 조성물 |
| CA2827029C (en) | 2011-02-11 | 2019-07-02 | The Regents Of The University Of Michigan | Tripeptide compositions and methods |
-
2012
- 2012-02-10 CA CA2827029A patent/CA2827029C/en active Active
- 2012-02-10 AU AU2012214283A patent/AU2012214283B2/en active Active
- 2012-02-10 WO PCT/US2012/024684 patent/WO2012109561A2/en not_active Ceased
- 2012-02-10 US US13/371,042 patent/US8664177B2/en active Active
- 2012-02-10 DK DK12709416.7T patent/DK2683393T3/en active
- 2012-02-10 EP EP12709416.7A patent/EP2683393B1/en active Active
- 2012-02-10 HU HUE12709416A patent/HUE038787T2/hu unknown
- 2012-02-10 CN CN201280008561.5A patent/CN103458911B/zh active Active
- 2012-02-10 ES ES12709416.7T patent/ES2673672T3/es active Active
- 2012-02-10 CN CN201610034403.7A patent/CN105617351A/zh active Pending
- 2012-02-10 MX MX2013009223A patent/MX353301B/es active IP Right Grant
- 2012-02-10 JP JP2013553601A patent/JP5946473B2/ja active Active
-
2013
- 2013-11-22 US US14/087,247 patent/US9062093B2/en active Active
-
2016
- 2016-05-31 JP JP2016108514A patent/JP6412897B2/ja active Active
-
2018
- 2018-03-29 JP JP2018064465A patent/JP2018131446A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012109561A2 (en) | 2012-08-16 |
| CN103458911A (zh) | 2013-12-18 |
| NZ614080A (en) | 2016-05-27 |
| JP2016179992A (ja) | 2016-10-13 |
| ES2673672T3 (es) | 2018-06-25 |
| CA2827029A1 (en) | 2012-08-16 |
| CN103458911B (zh) | 2016-02-24 |
| JP5946473B2 (ja) | 2016-07-06 |
| US20120208748A1 (en) | 2012-08-16 |
| US20140148382A1 (en) | 2014-05-29 |
| HUE038787T2 (hu) | 2018-11-28 |
| AU2012214283B2 (en) | 2016-01-28 |
| JP2018131446A (ja) | 2018-08-23 |
| DK2683393T3 (en) | 2018-07-23 |
| JP2014506579A (ja) | 2014-03-17 |
| JP6412897B2 (ja) | 2018-10-24 |
| CN105617351A (zh) | 2016-06-01 |
| NZ719672A (en) | 2018-12-21 |
| EP2683393A2 (en) | 2014-01-15 |
| MX2013009223A (es) | 2014-01-23 |
| EP2683393B1 (en) | 2018-04-11 |
| AU2012214283A1 (en) | 2013-08-29 |
| US8664177B2 (en) | 2014-03-04 |
| US9062093B2 (en) | 2015-06-23 |
| CA2827029C (en) | 2019-07-02 |
| WO2012109561A3 (en) | 2013-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX353301B (es) | Composiciones tripeptidicas y metodos para tratamiento de diabetes. | |
| MX340014B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX2012008998A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX2012009000A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX351414B (es) | Composicion farmaceutica para el tratamiento y/o prevencion de cancer pancreatico. | |
| MX336187B (es) | Metodo para tratar el mal de parkinson. | |
| WO2012014214A3 (en) | Peptides derived from plasminogen activator inhibitor-1 (pai-1) for the treatment of hypertension | |
| WO2010085700A3 (en) | Treatment for obesity | |
| MX2014001375A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| PH12014500923A1 (en) | Insulinotropic peptide derivative wherein its n-terminal amino acid is modified | |
| WO2008075371A3 (en) | T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation | |
| IN2012DN04085A (OSRAM) | ||
| EA201100072A1 (ru) | Новые композиции и способы | |
| MY167804A (en) | Treatment of degenerative joint disease | |
| MX2015011243A (es) | Peptidos para su uso en el tratamiento topico de enfermedades neurodegenerativas retinianas, en particular en fases de tempranas de retinopatia diabetica y otras enfermedades retinianas en las cuales la neurodegeneracion desempeña una funcion esencial. | |
| EP3932418A3 (en) | Peptides for use in promoting transport of glucose | |
| NZ715203A (en) | Heparan sulphates | |
| UA107180C2 (uk) | Туберкульозний білок rv1753c, композиція, що його містить, та застосування | |
| MX2014011614A (es) | Fragmentos y proteinas nutritivas con fenilalanina baja o nula y metodos. | |
| MX2016007407A (es) | Peptidos resistentes a proteasa. | |
| NZ601142A (en) | Composition for improving brain function and method for improving brain function | |
| NZ594268A (en) | Grass peptides for vaccine | |
| WO2012153337A3 (en) | Anti-microbial peptides and uses of same | |
| EP2552462A4 (en) | CCN3 THERAPEUTIC PEPTIDES AND THEIR ANALOGS | |
| MX2018014966A (es) | Peptidos monolipidados resistentes a proteasas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |